JZB-32

N/A

Report date: 2023/04/27 15:15:01

Base Information

Drug NameJZB-32
Drug Alias Name重组人截短型纤溶酶Ocriplasmin biosimilar(Jingze Biological)JZB-32
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen replacements
TargetsPlasminogen
Therapy Area/IndicationsVitreomacular AdhesionPolypoidal choroidal vasculopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Zeyan Biotechnology Co LtdJingze Biological Medicine (Hefei) Co LtdShanghai Jingze Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJingze Biological Medicine (Hefei) Co LtdShanghai Jingze Biotechnology Co LtdChengdu Zeyan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsVitreomacular AdhesionPolypoidal choroidal vasculopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A